AbbVie (ABBV) Tops Q4 EPS by 4c, Raises FY18 EPS Guidance
AbbVie (NYSE: ABBV) reported Q4 EPS of $1.48, $0.04 better than the analyst estimate of $1.44. Revenue for the quarter came in at $7.74 billion versus the consensus estimate of $7.53 billion.
GUIDANCE:
AbbVie sees FY2018 EPS of $7.33-$7.43, versus the consensus of $6.59.
For earnings history and earnings-related data on AbbVie (ABBV) click here.